Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to general corporate taxation; and implementation of PL 119-21.
Animal health, issues impacting medicines and vaccines for animals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| THE VANGUARD GROUP, INC. |
| 62 |
| 2009–2026 |
| TE CONNECTIVITY, INC. | 60 | 2011–2024 |
| ZOETIS | 58 | 2013–2026 |
| Buhler Quality Yarns Corporation | 57 | 2010–2026 |
| Tom James Company | 56 | 2010–2026 |
| ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) | 51 | 2012–2024 |
| AMERICAN ACADEMY OF EMERGENCY MEDICINE (AAEM) | 45 | 2013–2023 |
| NEW ENGLAND SHIRT CO | 44 | 2014–2026 |
| CHENIERE ENERGY | 42 | 2007–2017 |
| GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) | 38 | 2011–2020 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 38 | 2017–2026 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 38 | 2010–2021 |
| COCA-COLA COMPANY | 37 | 2007–2016 |
| INTERNATIONAL ASSOCIATION OF AMUSEMENT PARKS AND ATTRACTIONS | 37 | 2007–2019 |
| BROOKS BROTHERS | 36 | 2010–2020 |
| GITMAN AND COMPANY | 35 | 2010–2020 |
| UNITED AIRLINES, INC | 35 | 2008–2017 |
| HICKEY FREEMAN TAILORED CLOTHING, INC | 33 | 2014–2023 |
| SECURITY TRADERS ASSOCIATION | 33 | 2009–2018 |
| SUPIMA | 33 | 2010–2018 |
| CITY OF WESTMINSTER | 32 | 2010–2018 |
| SOUTHWICK CLOTHING, LLC. | 32 | 2010–2020 |
| INDIVIOR INC. | 31 | 2017–2024 |
| AMERICAN COUNCIL OF LIFE INSURERS | 30 | 2010–2018 |
| TRANSAMERICA COMPANIES (FORMLY AEGON) | 30 | 2010–2018 |
| WINE AND SPIRITS WHOLESALERS OF AMERICA | 30 | 2008–2016 |
| BRINKS COMPANY | 29 | 2009–2018 |
| STANLEY BLACK & DECKER INC | 29 | 2008–2026 |
| BRIGHT HOUSE NETWORKS | 28 | 2007–2014 |
| JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) | 28 | 2020–2026 |
| W DIAMOND GROUP CORPORATION | 28 | 2013–2026 |
| BLOOMBERG LP | 27 | 2020–2026 |
| ELI LILLY & COMPANY | 27 | 2020–2026 |
| NORFOLK SOUTHERN CORPORATION | 27 | 2008–2016 |
| NOVO NORDISK, INC. | 27 | 2020–2026 |
| AMERICAN BUSINESS GROUP OF ABU DHABI (D/B/A AMCHAM ABU DHABI) | 26 | 2015–2020 |
| ELLIOTT MANAGEMENT | 26 | 2020–2026 |
| FEDERATION OF EXCHANGE ACCOMODATORS, INC. | 26 | 2020–2026 |
| HOUSTON FIREFIGHTERS RELIEF AND RETIREMENT FUND | 26 | 2011–2017 |
| NOVARTIS, INC. | 26 | 2011–2017 |
| OWENS-ILLINOIS INC | 25 | 2011–2016 |
| OTC MARKETS | 23 | 2017–2023 |
| SYNEOS HEALTH, INC. | 23 | 2021–2026 |
| BOMBARDIER AEROSPACE HOLDINGS (USA) INC FORMERLY BOMBARDIER TRANSIT CORPORATION | 22 | 2021–2026 |
| DELL INC. | 22 | 2021–2026 |
| AMERICAN PUBLIC COMMUNICATIONS COUNCIL INC (APCC) | 21 | 2007–2014 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 20 | 2018–2023 |
| COLORADO WEST HEALTHCARE SYSTEM, INC. DBA COMMUNITY HOSPITAL | 20 | 2022–2026 |
| WRIGHT STATE UNIVERSITY | 20 | 2011–2017 |
| FIDELITY NATIONAL FINANCIAL | 18 | 2022–2026 |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 18 | 2014–2017 |
| NAVISTAR | 18 | 2007–2014 |
| SUNOCO INC | 18 | 2009–2015 |
| ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) | 17 | 2013–2016 |
| PROPERTY CASUALTY INSURERS ASSOCIATION OF AMERICA | 17 | 2015–2019 |
| TYCO ELECTRONICS | 17 | 2007–2011 |
| AMERICAN ASSOCIATION OF CROP INSURERS (AACI) | 16 | 2017–2021 |
| KANSAS DEPARTMENT OF COMMERCE | 16 | 2012–2015 |
| SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE | 16 | 2010–2019 |
| AMGEN, INC. | 15 | 2021–2026 |
| COLUMBUS REGIONAL AIRPORT AUTHORITY | 15 | 2008–2014 |
| DIRECT EDGE ECN | 15 | 2009–2014 |
| FOX VALLEY TECHNICAL COLLEGE | 15 | 2009–2014 |
| HAMILTON SHIRTS, LTD. | 15 | 2023–2026 |
| MAUS & HOFFMAN | 15 | 2023–2026 |
| OHIO POLICE AND FIRE PENSION FUND | 15 | 2016–2019 |
| KNIGHT CAPITAL GROUP | 14 | 2009–2013 |
| ROCHESTER TAILORED CLOTHING, INC. | 14 | 2023–2026 |
| SOUTHWESTERN COMPANY | 14 | 2023–2026 |
| TD AMERITRADE | 14 | 2017–2020 |
| ZIPPO MANUFACTURING COMPANY | 14 | 2008–2014 |
| BAYER CORPORATION | 13 | 2010–2014 |
| BIOBOT ANALYTICS | 13 | 2020–2023 |
| IMPERATIVE EXECUTION, INC. | 13 | 2023–2026 |
| IRHYTHM TECHNOLOGIES | 13 | 2021–2024 |
| TTX COMPANY | 13 | 2010–2014 |
| HARDWICK CLOTHES | 12 | 2020–2022 |
| TURNER ENTERPRISES, INC. | 12 | 2010–2014 |
| NEXTERA ENERGY INC | 11 | 2011–2014 |
| THE FRIEDKIN GROUP | 11 | 2020–2022 |
| AIR MEDICAL OPERATORS ASSOCIATION | 10 | 2009–2011 |
| INFO TECH INC | 10 | 2012–2014 |
| U S ISRAEL SCIENCE AND TECHNOLOGY FOUNDATION | 10 | 2008–2015 |
| EXPRESS SERVICES | 9 | 2007–2009 |
| FINANCIAL OVERSIGHT AND MANAGEMENT BOARD FOR PUERTO RICO | 9 | 2017–2019 |
| HMX LLC | 9 | 2010–2013 |
| I SQUARED CAPITAL ADVISORS (US) LLC | 9 | 2024–2026 |
| ORBIS OPERATIONS, LLC | 9 | 2013–2015 |
| ALORICA, INC. | 8 | 2020–2021 |
| AMERICAN ASSOCIATION OF RETIRED PERSONS | 8 | 2012–2014 |
| AMERICAN CAPITAL | 8 | 2010–2013 |
| CASH AMERICA INTERNATIONAL, INC. | 8 | 2010–2012 |
| EXIGER | 8 | 2024–2025 |
| MUNICIPAL SECURITIES RULEMAKING BOARD | 8 | 2020–2021 |
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Motion Picture, Television, and Entertainment Revitalization Act
Client: THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) · Firm: WILLIAMS AND JENSEN, PLLC
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21. S. 5552 and H.R. 10582, to provide tax incentives for certain motion picture and TV productions.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices. CMS RAPID Proposed Rule.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794).
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices. CMS RAPID Proposed Rule.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: NOVOCURE INC. · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794).
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Motion Picture, Television, and Entertainment Revitalization Act
Client: THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) · Firm: WILLIAMS AND JENSEN, PLLC
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21. S. 5552 and H.R. 10582, to provide tax incentives for certain motion picture and TV productions.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) · Firm: WILLIAMS AND JENSEN, PLLC
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; H.R. 1, One Big Beautiful Bill Act".
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: COMCAST CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Tax matters affecting cable television companies, including domestic corporate tax provisions; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HAMILTON SHIRTS, LTD. · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BUHLER QUALITY YARNS CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ELI LILLY & COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development and approval. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention, 340B Program. Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; H.R. 1, One Big Beautiful Bill Act, potential negative impacts on markets and customers of proposed withholding tax on dividend payments.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NEW ENGLAND SHIRT CO · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MAUS & HOFFMAN · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton and wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NOVO NORDISK INC. · Firm: WILLIAMS AND JENSEN, PLLC
Medication affordability and access; general diabetes prevention. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN. 340B.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MAUS & HOFFMAN · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton and wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BUHLER QUALITY YARNS CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ZOETIS · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to general corporate taxation; issues related to the intersection of human health and the human animal bond. PAW Act of 2025, H.R. 1842, and related issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: COMCAST CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Tax matters affecting cable television companies, including domestic corporate tax provisions; H.R. 1, One Big Beautiful Bill Act".
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TOM JAMES COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton and wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ZOETIS · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to general corporate taxation and related issues; issues related to the intersection of human health and the human animal bond. PAW Act of 2025, H.R. 1842, under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NEW ENGLAND SHIRT CO · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: W DIAMOND GROUP CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) · Firm: WILLIAMS AND JENSEN, PLLC
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TOM JAMES COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton and wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: W DIAMOND GROUP CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ROCHESTER TAILORED CLOTHING, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R.1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HAMILTON SHIRTS, LTD. · Firm: WILLIAMS AND JENSEN, PLLC
Duties on cotton fabrics; Farm Bill reauthorization and extension, and related provisions of H.R 1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ROCHESTER TAILORED CLOTHING, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Duties on wool fabrics; 2025 Farm Bill extension implementation; Farm Bill reauthorization and extension, and related provisions of H.R.1; Federal initiatives to support domestic manufacturing.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; H.R. 1, One Big Beautiful Bill Act, potential negative impacts on markets and customers of proposed withholding tax on dividend payments.
Freedom to Invest in Tomorrow’s Workforce Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026; and implementation of and guidance on related provisions enacted in PL 119-21. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Freedom to Invest in Tomorrow’s Workforce Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Freedom to Invest in Tomorrow’s Workforce Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Freedom to Invest in Tomorrow’s Workforce Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Investing in Our Communities Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026; and implementation of and guidance on related provisions enacted in PL 119-21. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Investing in Our Communities Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Investing in Our Communities Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Investing in Our Communities Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
ENABLE Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
ENABLE Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
ENABLE Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026; and implementation of and guidance on related provisions enacted in PL 119-21. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
ENABLE Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1255, "Investing in Our Communities Act". Proposals related to increasing educational savings in and expanding access to 529 college savings plans, or impacting Code section 529; H.R. 1151 and S. 756, the "Freedom to Invest in Tomorrow's Workforce Act". Proposals to broaden access for ABLE plans; S. 627 and HR 1436. Proposals to expand 529 plan qualified uses to include credentialing programs, and extend 529A ABLE provisions set to expire in 2026, as included in H.R. 1, One Big Beautiful Bill Act. Implementation of related provisions included in SECURE 2.0, enacted in Division T of the Consolidated Appropriations Act, 2023.
Issues related to general corporate taxation and related issues; issues related to the intersection of human health and the human animal bond. PAW Act of 2025, H.R. 1842, under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act.
Issues related to general corporate taxation; issues related to the intersection of human health and the human animal bond. PAW Act of 2025, H.R. 1842, and related issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act.
Monitor issues related to general corporate taxation; issues related to the intersection of human health and the human animal bond. PAW Act of 2025, H.R. 1842.
2026 · third_quarter · Q3
Trade issues impacting US-based companies.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. Issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Support for obesity drug coverage and access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Business and corporate tax issues, international tax reform; issues related to research and development.
Remote clinical trials, biomedical research & development.
Clinical trials and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21. Legislation and issues related to prior authorization. Issues related to TrumpRX.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVOCURE INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices. CMS RAPID Proposed Rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISON SOFTWARE, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to government software technology procurement.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SOUTHWESTERN COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues pertaining to J-Visa exchange visitor programs.
State Department Appropriations for international cultural exchange programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROCHESTER TAILORED CLOTHING, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MAUS & HOFFMAN via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HAMILTON SHIRTS, LTD. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TOM JAMES COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
W DIAMOND GROUP CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENTENE CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Issues related to health insurance and affordability.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BUHLER QUALITY YARNS CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
COLORADO WEST HEALTHCARE SYSTEM, INC. DBA COMMUNITY HOSPITAL via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Support for community hospitals and rural healthcare.
Medicare status; support for small community hospitals and rural healthcare.
Medicare status; support for small community hospitals and rural healthcare. Rural Community Hospital Demonstration Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STANLEY BLACK & DECKER INC via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21. S. 5552 and H.R. 10582, to provide tax incentives for certain motion picture and TV productions.
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Tax matters affecting cable television companies, including domestic corporate tax provisions; implementation of PL 119-21.
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including intellectual property, spectrum allocation, carriage and regulatory issues, broadband industry practices, data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BOMBARDIER AEROSPACE HOLDINGS (USA) INC FORMERLY BOMBARDIER TRANSIT CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
American Rescue Plan Implementation, FAA issues, Transportation Appropriations Bills in the House and Senate, Aerospace R&D Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
COSETTE PHARMACEUTICALS via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about estradiol patch supply and demand issues and discussions on FDA shortage evaluations.
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), SENATE
THE VANGUARD GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; potential negative impacts on markets and customers of proposed withholding tax on dividend payments. Monitor implementation of IRC sec. 530A.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
IMPERATIVE EXECUTION, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
SEC and FINRA equity market structure issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
REINSURANCE ASSOCIATION OF AMERICA via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
National Oceanic and Atmospheric Administration.
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ELLIOTT MANAGEMENT via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
"Inflation Reduction Act of 2022" (PL 117-169) implementation, regulations. Corporate governance issues, proxy rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIDELITY NATIONAL FINANCIAL via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
H.R. 3206, Protecting Americas Property Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FEDERATION OF EXCHANGE ACCOMODATORS, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Monitor any possible change to IRC 1031 including any impact on qualified intermediaries. Monitor all IRC 1031 tax regulatory issues, and any proposed regulation of qualified intermediaries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
BLOOMBERG LP via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BOMBARDIER AEROSPACE HOLDINGS (USA) INC FORMERLY BOMBARDIER TRANSIT CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
American Rescue Plan Implementation, FAA issues, Transportation Appropriations Bills in the House and Senate, Aerospace R&D Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Animal health, issues impacting medicines and vaccines for animals.
Issues related to general corporate taxation; and implementation of PL 119-21.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Trade issues impacting US-based companies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Support for obesity drug coverage and access.
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794).
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Business and corporate tax issues, international tax reform; issues related to research and development.
Clinical trials and research.
Remote clinical trials, biomedical research & development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVOCURE INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21.
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including intellectual property, spectrum allocation, carriage and regulatory issues, broadband industry practices, data privacy.
Tax matters affecting cable television companies, including domestic corporate tax provisions; implementation of PL 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLORADO WEST HEALTHCARE SYSTEM, INC. DBA COMMUNITY HOSPITAL via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Support for community hospitals and rural healthcare.
Medicare status; support for small community hospitals and rural healthcare. Rural Community Hospital Demonstration Reauthorization Act.
Medicare status; support for small community hospitals and rural healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOUTHWESTERN COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
State Department Appropriations for international cultural exchange programs.
Issues pertaining to J-Visa exchange visitor programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROCHESTER TAILORED CLOTHING, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MAUS & HOFFMAN via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HAMILTON SHIRTS, LTD. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TOM JAMES COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NEW ENGLAND SHIRT CO via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
W DIAMOND GROUP CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENTENE CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Issues related to health insurance and affordability.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BUHLER QUALITY YARNS CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE VANGUARD GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; potential negative impacts on markets and customers of proposed withholding tax on dividend payments. Monitor implementation of IRC sec. 530A.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
IMPERATIVE EXECUTION, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
SEC and FINRA equity market structure issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
UNISON SOFTWARE, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues related to government software technology procurement.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
STANLEY BLACK & DECKER INC via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REINSURANCE ASSOCIATION OF AMERICA via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
National Oceanic and Atmospheric Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ELLIOTT MANAGEMENT via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
"Inflation Reduction Act of 2022" (PL 117-169) implementation, regulations. Corporate governance issues, proxy rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIDELITY NATIONAL FINANCIAL via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
H.R. 3206, Protecting Americas Property Rights Act.
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FEDERATION OF EXCHANGE ACCOMODATORS, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Monitor any possible change to IRC 1031 including any impact on qualified intermediaries. Monitor all IRC 1031 tax regulatory issues, and any proposed regulation of qualified intermediaries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
BLOOMBERG LP via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BOMBARDIER AEROSPACE HOLDINGS (USA) INC FORMERLY BOMBARDIER TRANSIT CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
American Rescue Plan Implementation, FAA issues, Transportation Appropriations Bills in the House and Senate, Aerospace R&D Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
COLORADO WEST HEALTHCARE SYSTEM, INC. DBA COMMUNITY HOSPITAL via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Support for community hospitals and rural healthcare.
Medicare status; support for small community hospitals and rural healthcare.
Medicare status; support for small community hospitals and rural healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Animal health, issues impacting medicines and vaccines for animals.
Issues related to general corporate taxation; and implementation of PL 119-21.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
VISA via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Trade issues impacting US-based companies.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
Remote clinical trials, biomedical research & development.
Clinical trials and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVOCURE INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
I SQUARED CAPITAL ADVISORS (US) LLC via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Outreach on renewable energy project in Taoyuan City, Taiwan; U.S. International Development Finance Corporation which is not an option in the drop down box.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy and children's privacy, and rural broadband policies.
Tax issues affecting multichannel television companies, including R&D, interest deductibility and expensing of capital investments; implementation of PL 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including intellectual property, spectrum allocation, carriage and regulatory issues, open Internet/broadband industry practices, data privacy.
Tax matters affecting cable television companies, including domestic corporate tax provisions; implementation of PL 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHWESTERN COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues pertaining to J-Visa exchange visitor programs.
State Department Appropriations for international cultural exchange programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROCHESTER TAILORED CLOTHING, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MAUS & HOFFMAN via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HAMILTON SHIRTS, LTD. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TOM JAMES COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NEW ENGLAND SHIRT CO via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
W DIAMOND GROUP CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENTENE CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues related to Advance Premium Tax Credits (APTCs) and cost-sharing reductions.
Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BUHLER QUALITY YARNS CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE VANGUARD GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; potential negative impacts on markets and customers of proposed withholding tax on dividend payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
IMPERATIVE EXECUTION, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
SEC and FINRA equity market structure issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
REINSURANCE ASSOCIATION OF AMERICA via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
National Oceanic and Atmospheric Administration.
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. National Oceanic and Atmospheric Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ELLIOTT MANAGEMENT via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
"Inflation Reduction Act of 2022" (PL 117-169) implementation, regulations. Corporate governance issues, proxy rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIDELITY NATIONAL FINANCIAL via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
H.R. 3206, Protecting Americas Property Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FEDERATION OF EXCHANGE ACCOMODATORS, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Monitor any possible change to IRC 1031 including any impact on qualified intermediaries. Monitor all IRC 1031 tax regulatory issues, and any proposed regulation of qualified intermediaries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
BLOOMBERG LP via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2025 · fourth_quarter · Q4
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2025 · fourth_quarter · Q4
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE